Abstract
In vitro tumour models utilise various cancer cells and an appropriate extracellular matrix equivalent to recapitulate the in vivo tumour microenvironment. Three-dimensional tissue surrogates (e.g., decellularised tissue grafts, decellularised monolayers, hydrogels, electrospun fibres and sponges) are increasingly used as alternatives to conventional two-dimensional monolayer cultures to model the tissue environment more faithfully for drug development and screening. Herein, we critically assess the advances and shortfalls of these three-dimensional systems as in vitro models of cancer.
Original language | English (Ireland) |
---|---|
Journal | Drug Discovery Today |
Volume | 21 |
Issue number | 9 |
Publication status | Published - 1 Sep 2016 |
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Shologu, N., Szegezdi, E., Lowery, A., Kerin, M., Pandit, A. and Zeugolis, D.I.